Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism ILDR2 antagonists(Immunoglobulin-like domain-containing receptor 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Preclinical | IL | - | |
Multiple Sclerosis | Preclinical | IL | - | |
Rheumatoid Arthritis | Preclinical | IL | - |